Diagnostic Problems After Change in Brand of Lubricant Jelly
Authors: Jill M. Paulson, Kim Ariyabuddhiphongs, Gila Kriegel, James V. Hennessey
Journal: Annals of Internal Medicine (2012)

Letters6 November 2012Diagnostic Problems After Change in Brand of Lubricant JellyJill M. Paulson, MD, Kim Ariyabuddhiphongs, MD, Gila Kriegel, MD, and James V. Hennessey, MDJill M. Paulson, MDFrom Beth Israel Deaconess Medical Center, Boston, MA 02215.Search for more papers by this author, Kim Ariyabuddhiphongs, MDFrom Beth Israel Deaconess Medical Center, Boston, MA 02215.Search for more papers by this author, Gila Kriegel, MDFrom Beth Israel Deaconess Medical Center, Boston, MA 02215.Search for more papers by this author, and James V. Hennessey, MDFrom Beth Israel Deaconess Medical Center, Boston, MA 02215.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-157-9-201211060-00024 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: Quality initiatives will play a vital role in ensuring high-quality clinical outcomes as hospitals move toward cost-saving measures.Objective: To describe the ramifications and subsequent steps taken after changing the brand of lubricant jelly used at Beth Israel Deaconess Medical Center in Boston, Massachusetts.Methods and Findings: Our hospital changed the brand of lubricant jelly as a cost-saving measure, and our clinicians subsequently noticed changes in the results of 2 diagnostic procedures.In our thyroid biopsy clinic, operators use lubricant jelly to facilitate ultrasound conduction, and needles pass through the jelly during fine-needle aspiration procedures. The change in lubricant ...References1. Cibas ES, Ali SZ; NCI Thyroid FNA State of the science conference. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132:658-65. [PMID: 19846805] CrossrefMedlineGoogle Scholar2. Evantash E. Lubricant use during Pap sample collection. Marlborough, MA: Hologic; 2012. Accessed at www.thinprep.com/pdfs/misc-00579-001%20rev.003-lubricant%20letter.doc on 16 March 2012. Google Scholar Author, Article, and Disclosure InformationAffiliations: From Beth Israel Deaconess Medical Center, Boston, MA 02215.Note: Drs. Paulson and Ariyabuddhiphongs contributed equally to this manuscript.Acknowledgment: The authors would like to thank Mark Aronson, MD; Carol Bates, MD; Bolanle Bukoye, Edward O'Neill, MD; Jennifer Potter, MD; Joanne Schulze; Scot Sternberg, MS; and Helen Wang, MD, for their assistance with the manuscript.Disclosures: Dr. Hennessey: Fees for participation in review activities, such as data monitoring boards, statistical analysis, end point committees, and the like: Novo Nordisk Data Safety Monitoring Board for the Liraglutide (NN2211-1800) Study. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 6 November 2012Volume 157, Issue 9Page: 678-679KeywordsCytopathologyHealth careHospitalsPrimary careSafetySafety studiesStatistical dataThyroidUltrasound imaging ePublished: 6 November 2012 Issue Published: 6 November 2012 CopyrightCopyright © 2012 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...